X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.accesswire.com/743757/Edesa-Biotech-and-FDA-Agree-on-Primary-Endpoint-for-Phase-3-ARDS-Drug-Study
https://www.clinicaltrialsarena.com/news/health-canada-edesa-biotech-vitiligo/
https://www.globenewswire.com/news-release/2022/11/18/2558786/0/en/Pardeep-Nijhawan-Acquires-Beneficial-Ownership-of-Additional-Securities-of-Edesa-Biotech-Inc.html
https://www.accesswire.com/711094/Edesa-Biotech-Reports-Fiscal-3rd-Quarter-2022-Results
https://www.accesswire.com/689216/Edesa-Biotech-Reports-Enrollment-Milestone-in-Phase-3-ARDS-Study
https://www.accesswire.com/685522/Edesa-Biotech-to-Join-Ontario-Bioscience-Panel-Discussion
https://www.biospace.com/article/releases/edesa-biotech-marks-enrollment-milestone-in-dermatitis-study/?s=71
https://www.biospace.com/article/releases/edesa-biotech-reports-favorable-mortality-reductions-in-covid-19-study/?s=71
https://seekingalpha.com/news/3741906-edesa-down-20-paring-huge-gains-made-yesterday-from-covid-antibody-data
https://www.evaluate.com/vantage/articles/news/trial-results/edesa-finds-signal-severely-ill-covid-19-patients
Market Place
Share 
